Inventor · disambiguated record
Vito Guagnano
Also filed as: GUAGNANO VITO
33 granted patents·23 pending applications·349 citations·filing 2002–2024
96Inventor score
Top patents by PatentIndex Score
56 records- 0197US8815901B2Quinoline carboxamide derivatives as protein tyrosine kinase inhibitorsNOVARTIS AG·Filed 2013·Granted Aug 26, 2014·69 cites·9 claims
- 0295US8552002B2Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2005·Granted Oct 8, 2013·132 cites·43 claims
- 0395US8227462B2Pyrrolidine-1,2-dicarboxamide derivativesFAIRHURST ROBIN ALEC·Filed 2009·Granted Jul 24, 2012·28 cites·5 claims
- 0494US8759517B2Pyrirnidinyl aryl urea derivatives being FGF inhibitorsNOVARTIS AG·Filed 2012·Granted Jun 24, 2014·11 cites·1 claims
- 0594US8293746B2Pyrimidinyl aryl urea derivatives being FGF inhibitorsBOLD GUIDO·Filed 2006·Granted Oct 23, 2012·17 cites·5 claims
- 0692US8476268B2Pyrrolidine-1,2-dicarboxamide derivativesFAIRHURST ROBIN ALEC·Filed 2012·Granted Jul 2, 2013·17 cites·5 claims
- 0790US8969341B2Pyrazolopyrrolidine compoundsFURET PASCAL·Filed 2012·Granted Mar 3, 2015·8 cites·13 claims
- 0887US8710085B2Pyrrolidine-1,2-dicarboxamide derivativesGUAGNANO VITO·Filed 2013·Granted Apr 29, 2014·11 cites·2 claims
- 0985US8815926B2Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseasesNOVARTIS AG·Filed 2013·Granted Aug 26, 2014·8 cites·25 claims
- 1082US7652022B2Diaryl urea derivatives useful for the treatment of protein kinase dependent diseasesNOVARTIS AG·Filed 2003·Granted Jan 26, 2010·21 cites·9 claims
- 1181US7592349B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Sep 22, 2009·3 cites·14 claims
- 1281US7563894B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Jul 21, 2009·3 cites·10 claims
- 1378US7514447B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2006·Granted Apr 7, 2009·2 cites·6 claims
- 1477US8975417B2Pyrazolopyrrolidine derivatives and their use in the treatment of diseaseBORDAS VINCENT·Filed 2014·Granted Mar 10, 2015·6 cites·24 claims
- 1577US8030311B2Phenylacetamides suitable as protein kinase inhibitorsNOVARTIS AG·Filed 2006·Granted Oct 4, 2011·2 cites·10 claims
- 1675US10028955B2FGFR inhibitor for use in the treatment of hypophosphatemic disordersNOVARTIS AG·Filed 2016·Granted Jul 24, 2018·2 cites·6 claims
- 1775US7638523B2Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2007·Granted Dec 29, 2009·1 cites·14 claims
- 1873US2024398798A1Fgfr inhibitor for use in the treatment of hypophosphatemic disordersNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1971US6933290B22-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivativesNOVARTIS AG·Filed 2002·Granted Aug 23, 2005·1 cites·18 claims
- 2069US9556180B2Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interactionNOVARTIS AG·Filed 2014·Granted Jan 31, 2017·1 cites·11 claims
- 2168US9403827B2Substituted purinone compoundsFURET PASCAL·Filed 2014·Granted Aug 2, 2016·1 cites·10 claims
- 2268US7795288B2Thiazole and pyrazole derivatives as Flt-3 kinase inhibitorsNOVARTIS AG·Filed 2004·Granted Sep 14, 2010·3 cites·6 claims
- 2368US2024382457A1Biaryl derivatives as yap/taz-tead protein-protein interaction inhibitorsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 2467US8273882B2Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitorsFURET PASCAL·Filed 2009·Granted Sep 25, 2012·0 cites·22 claims
- 2567US2009264649A1Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptorsIRM LLC·Filed 2009·Application pending·0 cites
- 2666US9365576B2Pyrrolopyrrolidinone compoundsCOTESTA SIMONA·Filed 2013·Granted Jun 14, 2016·2 cites·12 claims
- 2763US2021308132A1Fgfr inhibitor for use in the treatment of hypophosphatemic disordersNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2861US2014378468A1N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1--1-methyl-ureaAICHHOLZ REINER·Filed 2014·Application pending·0 cites
- 2960US2014186469A1Pyrrolidine-1,2-dicarboxamide derivativesFAIRHURST ROBIN ALEC·Filed 2014·Application pending·0 cites
- 3058US12083101B2Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitorsNOVARTIS AG·Filed 2021·Granted Sep 10, 2024·0 cites·33 claims
- 3158US8674099B2Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitorsFURET PASCAL·Filed 2012·Granted Mar 18, 2014·0 cites·7 claims
- 3257US8536175B2Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitorsFURET PASCAL·Filed 2012·Granted Sep 17, 2013·0 cites·12 claims
- 3356US2011045511A1Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methodGRAUS PORTA DIANA·Filed 2009·Application pending·0 cites
- 3454US2010075337A1Method of identification of cells that show sensitivity to modulation of signalingh mediated by fibroblast growth factor receptor or a variant thereofGRAUS PORTA DIANA·Filed 2008·Application pending·0 cites
- 3553US2012315648A1Method of identification of cells that show sensitivity to modulation of signaling mediated by a fibroblast growth factor receptor or a variant thereofGRAUS PORTA DIANA·Filed 2012·Application pending·0 cites
- 3652US2013012704A1Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2012·Application pending·0 cites
- 3752US2013012476A1Compounds and compositions as protein kinase inhibitorsDING QIANG·Filed 2012·Application pending·0 cites
- 3852US2014343084A1Imidazopyrrolidinone compoundsNOVARTIS AG·Filed 2014·Application pending·0 cites
- 3952US2015323548A1Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methodsGRAUS PORTA DIANA·Filed 2015·Application pending·0 cites
- 4050US8940771B2Organic compoundsCARAVATTI GIORGIO·Filed 2008·Granted Jan 27, 2015·0 cites·8 claims
- 4150US2005239716A12-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}-alkylboronic acid derivativesFURET PASCAL·Filed 2005·Application pending·0 cites
- 4250US2016102062A1N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1--1-methyl-ureaAICHHOLZ REINER·Filed 2015·Application pending·0 cites
- 4350US2009062320A1Method of Treating Disorders Mediated by the Fibroblast Growth Factor ReceptorGUAGNANO VITO·Filed 2007·Application pending·0 cites
- 4449US7977338B2Phenylacetamides being FLT3 inhibitorsNOVARTIS AG·Filed 2007·Granted Jul 12, 2011·0 cites·4 claims
- 4548US9624247B2Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of diseaseBLANK JUTTA·Filed 2014·Granted Apr 18, 2017·0 cites·11 claims
- 4648US2012220600A1N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl) -1--1-methyl-ureaAICHHOLZ REINER·Filed 2010·Application pending·0 cites
- 4746US9890166B2Imidazopyrrolidine derivatives and their use in the treatment of diseaseBLANK JUTTA·Filed 2014·Granted Feb 13, 2018·0 cites·13 claims
- 4846US2016095843A1Pyrazolopyrrolidine derivatives and their use in the treatment of diseaseBLANK JUTTA·Filed 2014·Application pending·0 cites
- 4945US2012184561A1Phenylacetamides suitable as protein kinase inhibitorsBOLD GUIDO·Filed 2011·Application pending·0 cites
- 5044US2008312192A1Diaryl Urea Derivatives in the Treatment of Protein Kinase Dependent DiseasesBOLD GUIDO·Filed 2004·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →